GYNFO.COM ENEWS

October 10, 2005

 

 

Eblast Topics:   Diagnosing Ovarian Cancer

                            Élan MedSpa Open House Reminder

 

New research shows that it might be possible to diagnose ovarian cancer earlier by ordering certain tests for a patient experiencing non-specific symptoms.

Ovarian cancer is the No. 4 cause of cancer death in U.S. women, according to the American Cancer Society (ACS).

While ovarian cancer rates have been dropping since 1991, the disease remains the seventh most common cancer among American women (not counting skin cancer), and the fourth cause of cancer death in U.S. women according to the American Cancer Society (ACS).  Unfortunately, it is estimated that 75% to 80% of cases are diagnosed at an advanced stage.

Often, symptoms of ovarian cancer are subtle or even silent.  However, many women with this cancer report symptoms months earlier even with early-stage cancer.  Persistent symptoms can include:

  • Discomfort or cramping in the stomach or abdomen
  • Pelvic pressure or discomfort in the lower back
  • Gastrointestinal problems (such as persistent bloating or intestinal gas that isn't relieved by home treatments)
  • Abnormal vaginal bleeding
  • Change in bowel or bladder habits
  • Nausea, lack of appetite, drop in energy level

Those symptoms may not be associated with any ovarian disease, but may be worth an evaluation: first, a pelvic exam, followed by a pelvic ultrasound, and possibly a Ca-125 blood test. CA 125, a specific cancer screening test, is associated with a variety of noncancerous and common conditions including pelvic inflammatory disease, endometriosis, pregnancy, menstruation, and even fibroids. A normal blood level alone does not exclude a cancerous condition.

A recent medical study concludes that pelvic imaging and CA125 testing may lead to an earlier diagnosis in some patients, although the sensitivity of these tests for early stage disease is not high.

****

Elan Medspa’s Fall Open House is this Thursday October 13th from 5PM to 8PM at Dr. Birken’s office.  Many skin pharmaceutical reps will be available for consultation with discounts for purchased products.  Also, learn about optical laser, infrared, and intense pulse light treatments including the new Titan, a non-invasive facial lift.  Refreshments, snacks, and door prizes!

To RSVP, please contact Liz Birken at 832-287-6647 or email at ebirken@houston.rr.com

 

Randy Birken, MD
www.gynfo.com

 

Randy A. Birken, M.D.
17070 Red Oak Drive, Suite 201 A - Houston, TX 77090
Office: 281.893.1246  Fax: 281.444.6259

Copyright 2004 Randy A. Birken, M.D.  All Right Reserved
Disclaimer and Privacy Policy

www.gynfo.com